- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Glaucoma in Australia
Total 513 results
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Bristol-Myers SquibbTerminatedAdvanced CancerChile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
-
Medical University of GrazRecruitingMetastatic Cancer | Locally Advanced CarcinomaAustria
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingAdvanced Gastric or EGJ CancerGermany, Austria, Italy
-
Shanghai EpimAb Biotherapeutics Co., Ltd.TerminatedAdvanced Solid TumorsChina, Australia, United States
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Gilead SciencesRecruitingAdvanced Solid TumorUnited States, Australia, Taiwan, Spain, Canada
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
Endo PharmaceuticalsCompletedAdvanced Dupuytren's DiseaseAustralia
-
OncoSil Medical LimitedRecruitingLocally Advanced Pancreatic CancerSpain, Belgium, United Kingdom, Italy, Australia
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Bristol-Myers SquibbCompletedAdvanced TumorsUnited States, France, Australia, Spain, Canada
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
EpimAb Biotherapeutics (Suzhou)Co., Ltd.RecruitingAdvanced/Metastatic Solid Tumors | Relapse/Refractory LymphomaChina, Australia
-
Association of Research on the Biology of Liver...Completed
-
Wellmarker BioCovanceRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of, Australia
-
Shanghai Fosun Pharmaceutical Industrial Development...TerminatedAdvanced Cancer | Solid Tumors | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States, Australia
-
BeiGeneActive, not recruitingLocally Advanced and Metastatic Solid TumorsChina, Taiwan, United States, Australia
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
Redx Pharma PlcMerck Sharp & Dohme LLCCompletedAdvanced Solid TumoursUnited Kingdom, Australia
-
Medical University of ViennaRecruitingLocally Advanced and Metastatic Prostate CancerAustria
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Alpine Immune Sciences, Inc.TerminatedLymphoma | Advanced Solid TumorUnited States, Australia
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom, Spain
-
Xennials Therapeutics Australia Pty LtdPinotbio, Inc.TerminatedAdvanced Solid Tumor | High-grade Glioma | Platinum-Resistant Ovarian Cancer | Platinum-Resistant Urothelial CarcinomaAustralia
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Immix Biopharma Australia Pty LtdActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Solid Tumor, AdultUnited States, Australia
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Turkey, United Kingdom, Switzerland, Italy
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced CancerSpain, Argentina, United States, Korea, Republic of, Taiwan, Belgium, Romania, Germany, United Kingdom, Australia, Brazil, Canada, China, Czechia, Denmark, France, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Mexico, Netherlands, ... and more
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, France, Israel, Australia, Finland
-
Immunocore LtdRecruitingAdvanced MelanomaUnited States, Australia
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsCanada, United States, Argentina, France, Spain, Italy, Australia, Mexico, Chile
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland